Is Cross-Border Reproductive Care Legal?

Medically Reviewed by Dr. Silvana Chedid on August 12, 2026

Cross-border reproductive care, sometimes called fertility tourism, is legal for most patients, but the specific rules depend entirely on which two countries are involved and which procedure is being performed. There is no single international law governing IVF, egg donation, or surrogacy; instead, each country regulates assisted reproduction on its own terms, and your home country’s laws still apply to questions like parentage and citizenship once you return.

At Chedid Grieco, we support patients pursuing cross-border reproductive care at our FDA-registered, New York State Department of Health-licensed clinic in São Paulo, Brazil. Understanding the legal landscape before you travel, not after, is what keeps a cross-border treatment plan straightforward instead of stressful. This guide breaks down what cross-border reproductive care actually involves, why patients pursue it, how Brazil and the US regulate it differently, and what to verify before choosing a clinic.

What Exactly Is Cross-Border Reproductive Care?

Cross-border reproductive care involves traveling to a country other than your own to receive fertility treatment. It covers a range of services, including in vitro fertilization (IVF), egg or sperm donation, and surrogacy arrangements.

The primary reasons people pursue reproductive care abroad include lower costs, access to technology or treatments not available at home, and, for some patients, the ability to find legally permitted care that their home jurisdiction restricts or does not offer. For many, cross-border care offers a path to parenthood that would otherwise be far more difficult, though it comes with its own legal considerations that vary by destination.

How Brazil Regulates Assisted Reproduction

Brazil oversees assisted reproduction nationally through the Federal Council of Medicine, known as the CFM, under a single binding resolution rather than a patchwork of regional rules. The current framework, Resolution CFM No. 2.320/2022, sets ethical and clinical standards that every accredited Brazilian clinic must follow, and it explicitly includes single individuals and same-sex couples in its eligibility rules for assisted reproduction. It also caps embryo development in the laboratory at fourteen days and requires that patients give informed, written consent before treatment begins.

Our detailed look at how IVF is regulated at clinics abroad walks through the CFM framework in more depth, including how it compares clinic by clinic. Facility-level oversight in Brazil runs alongside CFM ethics rules through ANVISA, the national health surveillance agency, which inspects laboratories and tissue-handling standards.

How US Regulation Differs, and Why That Matters for Cross-Border Patients

In the United States, oversight of assisted reproduction is split across multiple federal agencies. The FDA handles donor tissue screening, the CDC collects clinic-level outcome data through the national ART Surveillance system, and individual states set their own rules for insurance coverage and embryo disposition. That patchwork became national news in February 2024, when the Alabama Supreme Court ruled in LePage v. Center for Reproductive Medicine that frozen embryos could be considered “unborn children” under the state’s wrongful death statute, a decision the Alabama legislature moved to override with new IVF-protection legislation within three weeks. The episode illustrated how differently individual states can treat the same procedure, and why patients researching options abroad often find a single national standard easier to plan around than the mix of state rules at home.

This same patchwork is part of why single intended parents look at international options more seriously than they might expect. Eligibility for single patients under a US clinic’s own policy can vary even where state law is silent on the question.

Why People Choose Reproductive Care Abroad

Cost is one of the most common motivators. Treatments abroad can be significantly more affordable than equivalent care at home, and some countries offer reproductive technologies or protocols that are restricted or unavailable domestically. Waiting times for treatment, particularly for donor eggs or sperm, can also be considerably shorter abroad, which matters for patients where age is a factor in their fertility.

Legal restrictions around specific procedures, such as IVF, surrogacy, or the use of donor gametes, play a role in the decision for many patients as well. Privacy is another consideration some patients weigh, preferring to undergo treatment away from their usual social circles. Each of these factors reflects a different personal calculation, but all of them intersect with the legal question of what is actually permitted where you are going and where you live.

How to Choose the Right Country and Clinic

Start by researching clinics that are accredited under their home country’s regulatory body and that also hold credentials recognized by US authorities. Chedid Grieco holds both FDA registration and a New York Department of Health tissue license, placing us among a small number of facilities outside the United States operating under that combination of oversight.

Beyond licensing, consider the clinic’s experience with international patients, the range of services offered, and the support provided throughout treatment, including how the clinic coordinates with US-based physicians for pre- and post-treatment care. Look for reviews from other international patients and ask specifically about the clinic’s published success rates for your treatment type. At Chedid Grieco, we have supported nearly 9,000 births over almost 30 years of practice, a track record we are glad to walk through in detail during a consultation.

What Cross-Border Care Does Not Automatically Resolve

Being legally treated in another country does not automatically resolve every legal question you may have at home. Parentage recognition, citizenship for a child conceived abroad, and any documentation required by your home country’s immigration authorities are governed by your own country’s law, not the country where treatment took place. Patients should confirm these specifics with an attorney familiar with international reproductive law before finalizing travel plans, particularly for surrogacy arrangements, where legal recognition varies more widely between countries than it does for IVF or egg donation.

Frequently Asked Questions About Cross-Border Reproductive Care

Interested in Cross-Border Reproductive Care? Contact Chedid Grieco Today

If you are ready to explore your options for cross-border reproductive care, we are here to help. The team at Chedid Grieco is committed to guiding you through every step, from your first consultation through treatment and aftercare. Patients from Miami can access top-tier fertility care at our Brazil clinic while benefiting from reduced costs and personalized support.

Visit our fertility tourism page to learn more about the advantages of traveling for treatment. We have supported nearly 9,000 births, and we would love to help you, too. For more information, reach out through our contact form and our team will be in touch.